@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns3:encourage . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-06-01T13:29:54.795919"^^xsd:dateTime . rdf:OBJECT rdfs:label "data" . rdf:OBJECT-POSITION rdfs:label "(0, 13)" . rdf:PREDICATE rdfs:label "encouraging" . rdf:PREDICATE-POSITION rdfs:label "37" . rdf:SUBJECT rdfs:label "Dexamethasone and tocilizumab showed" . rdf:SUBJECT-POSITION rdfs:label "(0, 13)" . rdf:Statement rdfs:label "Dexamethasone and tocilizumab showed encouraging data, but Dexamethasone and tocilizumab's use needs to be further validated." . rdfs:ABSTRACT-UID ns1:50 "fp4chn9a" . rdfs:TRIPLE-UID ns2:fp4chn9a-TRIPLE-ABSTRACT-2 "fp4chn9a-TRIPLE-ABSTRACT-2" . rdfs:label "dexamethasone" . rdfs:label "data" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "HbswYS97C30XoRx3mDxED+5ysbbsw4NpVIQSQv2SF+w3MwINXYZXUwGafIHGYmPDbXR6H0EWuy8tnUhGLP8+vd9t+tr7H+6KHw4vIDNqMADMrId8qFmFQfFMagJRgBpAdZ1S3L4kYLxPkrq1ydgwkvco3BRRcxlWANdvyPDgAk3lDJVR9bzlq1cB2A9FlkQ1mqhcrKpfLDpAHL9wzGgCLxf5n9LsSDeQIcTXNbnp4+ibQMwcsgGSkqMiGgYeUjn/ohVwfvwbgjLlgRcUkxezHGJIx2xYe5r1c8b77DRcQ9TxqRawjqqAEOqbTt0C3EikJrGY3fiypkQ1WmdSa+YZzxkwfI/nH7JOIFtZBgMBrNMqXqNbA1PvkcU4Hlabw/b0LRvYizEf71C19q0or459DD47PbOMAO2qfA5Kn+mjUFkTcdH8MlGDqfa1IGPzyivEhe9LdhvM4KQx/nWpRdQs6ACJFkIhGLXjWz20PIdQbHMphmlsRPClkxRmUI2pnl8i"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }